By KATIE THOMAS
Boehringer Ingelheim said that it stood behind the safety of Pradaxa and believed the lawsuits lacked merit, but that settling the case allowed it to move on.
Published: May 29, 2014 at 4:00AM
from NYT Business Day http://ift.tt/1k21dmA
via IFTTT
from WordPress http://ift.tt/1toByEs
No comments:
Post a Comment